Ruben Rizzi | SVP Global Regulatory Affairs
BioNTech SE
Ruben Rizzi, physician by training, SVP of Global Regulatory Affairs at BioNTech. I joined the company in December 2019 just before the pandemic, and I have been the global regulatory lead for BioNTech for our COVID-19 development. Currently, I am still supporting the lifecycle of our COVID-19 vaccine, and I am co-leading the Global Regulatory Affairs department at BioNTech and working closely with the teams that are responsible for the development of BioNTech´s pipeline, post-approval activities and labelling
Appearances:
Main Congress Day 2 - 23rd April @ 11:40
Panel: Do we need a perfectly matching strain in our next COVID vaccines?
- The epidemiology and efficiency of strain matching thus far
- Will our new vaccines work better than our old ones for the immune population?
- Who are our COVID vaccines for and how to we sustain uptake?
- What are the clinical consequences of imprinting? How do we to measure this, do other platform act differently?
Main Congress Day 2 - 23rd April @ 17:25
Panel: Disease X – how can we be better prepared for the unknown?
Main Congress Day 3 - 24th April @ 09:10
New proposals for better pandemic preparedness frameworks: Ongoing initiatives and future perspectives
last published: 15/Jan/25 16:15 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events